XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statement of Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Total U.S. Bancorp Shareholders’ Equity
Common Stock
Preferred Stock
Capital Surplus
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Beginning Balance (in shares) at Dec. 31, 2023     1,558            
Beginning Balance at Dec. 31, 2023 $ 55,771 $ 55,306 $ 21 $ 6,808 $ 8,673 $ 74,026 $ (24,126) $ (10,096) $ 465
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 1,326 1,319       1,319     7
Other comprehensive income (loss) (257) (257)           (257)  
Preferred stock dividends [1] (102) (102)       (102)      
Common stock dividends (770) (770)       (770)      
Issuance of common and treasury stock (in shares)     3            
Issuance of common and treasury stock 13 13     (139)   152    
Purchase of treasury stock (in shares)     (1)            
Purchase of treasury stock (49) (49)         (49)    
Distributions to noncontrolling interests (7)               (7)
Stock option and restricted stock grants 108 108     108        
Ending Balance (in shares) at Mar. 31, 2024     1,560            
Ending Balance at Mar. 31, 2024 56,033 55,568 $ 21 6,808 8,642 74,473 (24,023) (10,353) 465
Beginning Balance (in shares) at Dec. 31, 2024     1,560            
Beginning Balance at Dec. 31, 2024 59,040 58,578 $ 21 6,808 8,715 76,863 (24,065) (9,764) 462
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 1,716 1,709       1,709     7
Other comprehensive income (loss) 722 722           722  
Preferred stock dividends [2] (95) (95)       (95)      
Common stock dividends (786) (786)       (786)      
Issuance of common and treasury stock (in shares)     4            
Issuance of common and treasury stock 16 16     (149)   165    
Purchase of treasury stock (in shares)     (4)            
Purchase of treasury stock (160) (160)         (160)    
Distributions to noncontrolling interests (7)               (7)
Stock option and restricted stock grants 112 112     112        
Ending Balance (in shares) at Mar. 31, 2025     1,560            
Ending Balance at Mar. 31, 2025 $ 60,558 $ 60,096 $ 21 $ 6,808 $ 8,678 $ 77,691 $ (24,060) $ (9,042) $ 462
[1] Reflects dividends declared per share on the Company’s Series A, Series B, Series J, Series K, Series L, Series M, Series N and Series O Non-Cumulative Perpetual Preferred Stock of $1,667.221, $390.264, $662.50, $343.75, $234.375, $250.00, $231.25 and $281.25, respectively.
[2] Reflects dividends declared per share on the Company’s Series A, Series B, Series J, Series K, Series L, Series M, Series N and Series O Non-Cumulative Perpetual Preferred Stock of $1,395.898, $322.724, $662.50, $343.75, $234.375, $250.00, $231.25 and $281.25, respectively.